Viral Vector Manufacturing - Global Market Outlook (2017-2026)

Viral Vector Manufacturing - Global Market Outlook (2017-2026)

  • Published: March 2019
  • ID: SMRC18110

According to Stratistics MRC, the Global Viral Vector Manufacturing Market is accounted for $227.63 million in 2017 and is expected to reach $1013 million by 2026 growing at a CAGR of 18.0% during the forecast period. The increasing prevalence of target diseases and disorders, a rising number of clinical studies and availability of funding for gene therapy development, and potential applications in novel drug delivery approaches are some of the factors propelling the market growth. However, the excessive cost of gene therapies and possible mutagenesis impede the market.

Viral Vector Manufacturing comprises the generation of these vectors, which then have to be purified in order to meet the quality attributes required for further use as gene delivery systems. Viral or non-viral vector methods are used the inefficient transfer of the therapeutic gene into the target cells. Viral vectors used in gene therapy include adenovirus, lentivirus, retrovirus, and adeno-associated viral (AAV). Non-viral vectors generally depend on delivery of plasmid DNA.

On the basis of application, Gene Therapy segment holds the significant growth during the forecast period due to the availability of effective viral vector gene therapies for rare diseases & cancers, ongoing research activities on viral vector gene therapies.

Based on geography, North America holds the major market share during the forecast period owing to rise in research activities, a large number of regenerative medicine companies, increase in the prevalence of target diseases and availability of funds.

Some of the key players profiled in the Viral Vector Manufacturing Market include Spark Therapeutics, Uniqure, Kaneka Eurogentec, Regenxbio, Finvector Vision Therapies, Novasep, Massbiologics, Merck KGaA, Cobra Biologics, Fujifilm Holdings Corporation, Lonza, Brammer Bio, Oxford Biomedica and Thermo Fisher Scientific Inc.

Types Covered:
• Adenoviral Vectors
• Retroviral Vectors
• Adeno-Associated Viral Vectors
• Pox Virus
• Cytomegalovirus
• Other Types

Diseases Covered:
• Human Disease
• Veterinary Disease

Applications Covered:
• Vaccinology
• Gene Therapy

End Users Covered:
• Research Institutes
• Pharmaceutical and Biopharmaceutical Companies
• Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
    o Comprehensive profiling of additional market players (up to 3)
    o SWOT Analysis of key players (up to 3)
• Regional Segmentation
    o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
    o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary           
             
2 Preface            
 2.1 Abstract           
 2.2 Stake Holders          
 2.3 Research Scope          
 2.4 Research Methodology         
  2.4.1 Data Mining         
  2.4.2 Data Analysis         
  2.4.3 Data Validation         
  2.4.4 Research Approach         
 2.5 Research Sources          
  2.5.1 Primary Research Sources        
  2.5.2 Secondary Research Sources        
  2.5.3 Assumptions         
             
3 Market Trend Analysis          
 3.1 Introduction          
 3.2 Drivers           
 3.3 Restraints          
 3.4 Opportunities          
 3.5 Threats           
 3.6 Application Analysis          
 3.7 End User Analysis          
 3.8 Emerging Markets          
 3.9 Futuristic Market Scenario         
             
4 Porters Five Force Analysis          
 4.1 Bargaining power of suppliers         
 4.2 Bargaining power of buyers         
 4.3 Threat of substitutes         
 4.4 Threat of new entrants         
 4.5 Competitive rivalry          
             
5 Global Viral Vector Manufacturing Market, By Type        
 5.1 Introduction          
 5.2 Adenoviral Vectors           
 5.3 Retroviral Vectors           
  5.3.1 Gamma-Retroviral Vectors        
  5.3.2 Lentiviral Vectors         
 5.4 Adeno-Associated Viral Vectors         
 5.5 Pox Virus           
 5.6 Cytomegalovirus          
 5.7 Other Types          
  5.7.1 Herpes Simplex Virus Vectors        
             
6 Global Viral Vector Manufacturing Market, By Disease         
 6.1 Introduction          
 6.2 Human Disease          
  6.2.1 Infectious Diseases          
   6.2.1.1 Influenza         
   6.2.1.2 Malaria         
   6.2.1.3 Hepatitis         
  6.2.2 Genetic Disorders          
   6.2.2.1 Human Immunodeficiency Virus (HIV)      
   6.2.2.2 Tuberculosis        
  6.2.3 Cancer           
  6.2.4 Other Human Diseases        
 6.3 Veterinary Disease          
  6.3.1 Avian Influenza         
  6.3.2 Marek's Disease         
  6.3.3 Infectious Bronchitis        
  6.3.4 Peste des Petits Ruminants (PPR) Disease      
  6.3.5 Other Veterinary Diseases        
   6.3.5.1 Rabies         
   6.3.5.2 Fibromuscular Dysplasia (FMD)      
   6.3.5.3 Swine Influenza        
   6.3.5.4 Equine Influenza        
   6.3.5.5 Newcastle Disease         
             
7 Global Viral Vector Manufacturing Market, By Application         
 7.1 Introduction          
 7.2 Vaccinology          
  7.2.1 Multivalent Vaccines        
  7.2.2 Multipathogen Vaccines        
 7.3 Gene Therapy          
              
8 Global Viral Vector Manufacturing Market, By End User         
 8.1 Introduction          
 8.2 Research Institutes          
 8.3 Pharmaceutical and Biopharmaceutical Companies       
 8.4 Other End Users          
             
9 Global Viral Vector Manufacturing Market, By Geography       
 9.1 Introduction          
 9.2 North America          
  9.2.1 US          
  9.2.2 Canada          
  9.2.3 Mexico          
 9.3 Europe           
  9.3.1 Germany          
  9.3.2 UK           
  9.3.3 Italy          
  9.3.4 France          
  9.3.5 Spain          
  9.3.6 Rest of Europe         
 9.4 Asia Pacific          
  9.4.1 Japan          
  9.4.2 China          
  9.4.3 India          
  9.4.4 Australia          
  9.4.5 New Zealand         
  9.4.6 South Korea         
  9.4.7 Rest of Asia Pacific         
 9.5 South America          
  9.5.1 Argentina         
  9.5.2 Brazil          
  9.5.3 Chile          
  9.5.4 Rest of South America        
 9.6 Middle East & Africa         
  9.6.1 Saudi Arabia         
  9.6.2 UAE          
  9.6.3 Qatar          
  9.6.4 South Africa         
  9.6.5 Rest of Middle East & Africa        
             
10 Key Developments           
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures      
 10.2 Acquisitions & Mergers         
 10.3 New Product Launch         
 10.4 Expansions          
 10.5 Other Key Strategies         
             
11 Company Profiling           
 11.1 Spark Therapeutics           
 11.2 Uniqure           
 11.3 Kaneka Eurogentec          
 11.4 Regenxbio          
 11.5 Finvector Vision Therapies         
 11.6 Novasep           
 11.7 Massbiologics          
 11.8 Merck KGaA          
 11.9 Cobra Biologics           
 11.10 Fujifilm Holdings Corporation         
 11.11 Lonza            
 11.12 Brammer Bio          
 11.13 Oxford Biomedica          
 11.14 Thermo Fisher Scientific Inc.         


List of Tables            
1 Global Viral Vector Manufacturing Market Outlook, By Region (2016-2026) ($MN)     
2 Global Viral Vector Manufacturing Market Outlook, By Type (2016-2026) ($MN)     
3 Global Viral Vector Manufacturing Market Outlook, By Adenoviral Vectors (2016-2026) ($MN)    
4 Global Viral Vector Manufacturing Market Outlook, By Retroviral Vectors (2016-2026) ($MN)    
5 Global Viral Vector Manufacturing Market Outlook, By Gamma-Retroviral Vectors (2016-2026) ($MN)   
6 Global Viral Vector Manufacturing Market Outlook, By Lentiviral Vectors (2016-2026) ($MN)    
7 Global Viral Vector Manufacturing Market Outlook, By Adeno-Associated Viral Vectors (2016-2026) ($MN)  
8 Global Viral Vector Manufacturing Market Outlook, By Pox Virus (2016-2026) ($MN)    
9 Global Viral Vector Manufacturing Market Outlook, By Cytomegalovirus (2016-2026) ($MN)    
10 Global Viral Vector Manufacturing Market Outlook, By Other Types (2016-2026) ($MN)    
11 Global Viral Vector Manufacturing Market Outlook, By Herpes Simplex Virus Vectors (2016-2026) ($MN)   
12 Global Viral Vector Manufacturing Market Outlook, By Disease (2016-2026) ($MN)     
13 Global Viral Vector Manufacturing Market Outlook, By Human Disease (2016-2026) ($MN)    
14 Global Viral Vector Manufacturing Market Outlook, By Infectious Diseases (2016-2026) ($MN)    
15 Global Viral Vector Manufacturing Market Outlook, By Genetic Disorders (2016-2026) ($MN)    
16 Global Viral Vector Manufacturing Market Outlook, By Cancer (2016-2026) ($MN)     
17 Global Viral Vector Manufacturing Market Outlook, By Other Human Diseases (2016-2026) ($MN)   
18 Global Viral Vector Manufacturing Market Outlook, By Veterinary Disease (2016-2026) ($MN)    
19 Global Viral Vector Manufacturing Market Outlook, By Avian Influenza (2016-2026) ($MN)    
20 Global Viral Vector Manufacturing Market Outlook, By Marek's Disease (2016-2026) ($MN)    
21 Global Viral Vector Manufacturing Market Outlook, By Infectious Bronchitis (2016-2026) ($MN)   
22 Global Viral Vector Manufacturing Market Outlook, By Peste des Petits Ruminants (PPR) Disease (2016-2026) ($MN) 
23 Global Viral Vector Manufacturing Market Outlook, By Other Veterinary Diseases (2016-2026) ($MN)   
24 Global Viral Vector Manufacturing Market Outlook, By Application (2016-2026) ($MN)    
25 Global Viral Vector Manufacturing Market Outlook, By Vaccinology (2016-2026) ($MN)    
26 Global Viral Vector Manufacturing Market Outlook, By Multivalent Vaccines (2016-2026) ($MN)   
27 Global Viral Vector Manufacturing Market Outlook, By Multipathogen Vaccines (2016-2026) ($MN)   
28 Global Viral Vector Manufacturing Market Outlook, By Gene Therapy (2016-2026) ($MN)    
29 Global Viral Vector Manufacturing Market Outlook, By End User (2016-2026) ($MN)     
30 Global Viral Vector Manufacturing Market Outlook, By Research Institutes (2016-2026) ($MN)    
31 Global Viral Vector Manufacturing Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2016-2026) ($MN) 
32 Global Viral Vector Manufacturing Market Outlook, By Other End Users (2016-2026) ($MN)     
             
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials